Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

 

Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
E

UPenn ASH Highlights on PI3Ki & BTKi for R/R MZL: How Effective Are Parsaclisib & Zanubrutinib?

By Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient FEATURING Elise Chong
By Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient FEATURING Elise Chong
0 views
March 2, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
New Therapies and Current Patient Management of Lymphomas
16:47
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Overview of New Therapies and Current Management of CLL, SLL & R…

Feat. J. Gerson
08:09
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Updates on MCL: Ibrutinib + Ven, Len + Rituximab, 1L Sequential Immu…

Feat. J. Gerson
07:39
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

UPenn 2021 Updates on PTCL: Does the Addition of Romidepsin to CHOP …

Feat. J. Svoboda
07:09
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Older Adults With cHL: Considering Brentuximab Vedotin Mono & Co…

Feat. J. Svoboda
10:50
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

ASH Updates on R/R cHL: How to Consider Pembro-GVH? What Is the Role…

Feat. J. Svoboda
17:46
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

UPenn Expert Discussion on Lymphoma: Efficacy of Acalabrutinib for S…

Feat. S. Schuster, J. Gerson, J. Svoboda, E. Chong, S. Nasta, D. Beach, G. Hanna
10:41
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

ASH Updates on Large Cell & Aggressive Lymphomas: Antibody Lonca…

Feat. S. Nasta
09:00
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

ASH Updates on Lymphomas: 1L (Axi-Cel) in High-Risk DLBCL, Safety, D…

Feat. S. Nasta
09:41
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

UPenn ASH Highlights on PI3Ki & BTKi for R/R MZL: How Effective …

Feat. E. Chong
10:32
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

UPenn ASH Highlights on CAR-T & Bispecific Antibodies for iNHL: …

Feat. E. Chong